Aclaris Files for Secondary Offering
Aclaris Therapeutics saw its shares make a handy gain on Friday after the company announced the pricing of its secondary offering.
All Work
Chris Lange
EyeGate Pharma Rises After FDA Meeting
Eyegate Pharmaceuticals saw its shares make a strong gain to close out the week after the company announced an update from its meeting with the FDA.
4 Companies That Destroyed Shareholders Last Week
Now that the U.S. presidential election is over and markets have recovered to their highs, there are still some stocks holding back the markets from breaking even higher.
Ardagh Registers for IPO
Ardagh Finance Holdings has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Why Abercrombie & Fitch Earnings Fell Flat
Abercrombie & Fitch reported disappointing fiscal third-quarter financial results before the markets opened on Friday.
How Marvell Won Big in Q3
Marvell Technology Group Ltd. (NASDAQ: MRVL) reported fiscal third-quarter financial results after markets closed on Thursday. The company said that it had $0.20 in earnings per share (EPS) and $654 million in revenue. The…
Salesforce Wows With Earnings
Salesforce.com, Inc. (NYSE: CRM) released fiscal third-quarter financial results after markets closed on Thursday. The company posted $0.24 in earnings per share (EPS) and $2.14 billion in revenue. There were consensus estimates from Thomson…
SEC Charges JPMorgan With FCPA Violation
The U.S. Securities and Exchange Commission (SEC) recently announced that JPMorgan Chase & Co. (NYSE: JPM) has agreed to pay over $130 million to settle charges that it won business from clients and corruptly…
What to Look for in Salesforce Earnings
Salesforce.com is set to release its fiscal third-quarter financial results after the markets close on Thursday.
What Analysts Are Saying About Target After Earnings
Target shares made solid gains on Wednesday after the earnings report, keeping itself in line with the broad markets. Analysts may have mixed views on this stock, but across the board they raised their…
What to Expect From Marvell Earnings
Marvell Technology is scheduled to report its fiscal third-quarter financial results after the markets close on Thursday.
BeiGene Prices Secondary Offering
BeiGene intends to offer more than 4 million American depositary shares in a secondary offering valued up to more than $201 million.
How Best Buy Won With This Earnings Report
When Best Buy reported its fiscal third-quarter financial results before the markets opened on Thursday, it posted continued growth on both the top and bottom lines, which put it in line with most other…
Why Cisco’s Solid Earnings Aren’t Enough for Investors
When Cisco Systems reported its fiscal first-quarter financial results after the markets closed on Wednesday, overall the networking giant had a good quarter, posting beats on both the top and bottom lines.
SEC Announces Plan to Create Consolidated Audit Trail
The U.S. Securities and Exchange Commission (SEC) recently voted to approve a national market system (NMS) plan to create a single, comprehensive database known as the consolidated audit trail (CAT). Ultimately this program will…
What to Expect From Wal-Mart Earnings
Wal-Mart Stores is scheduled to report its fiscal third-quarter financial results before the markets open on Thursday.
Aurinia Pharmaceuticals Rises on Positive Mid-Stage Update
Shares of Aurinia Pharmaceuticals saw a handy gain on Wednesday after the company gave an update on its lupus nephritis treatment.
iPhone Most Wished For Holiday Tech Gift
24/7 Wall St. is taking a closer look at holiday spending and what consumers are going after this year. No surprise, the iPhone 7 tops most Christmas lists.
AnaptysBio Files for IPO
AnaptysBio has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Why Target Earnings Made the Cut
Target is rounding out the major retailers reporting third-quarter results ahead of the holiday season, and just like most others Target hit the mark.